Amolyt Pharma
FranceAmolyt Pharma is a healthcare company, headquartered in France.
Entry
2019
Hold
5yr
Exit
2024
Est. EV
–
Who owns Amolyt Pharma?
Amolyt Pharma was owned by Kurma Partners through Kurma Growth Opportunities (2024 vintage) from 2019 to 2024. Across its history, Amolyt Pharma has been through 6 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Kurma PartnersKurma Growth Opportunities · 2024 · Growth
7 ownership periods · full history below
Key facts
HQFrance
SectorHealthcare
Key takeaways
- ·Fully exited in 2024.
- ·Average hold across 7 realized cycles: 5 years.
- ·6 distinct PE sponsors across ownership cycles.
Ownership history
7 ownership periods · co-invest detected
Exited
Last exited in 2024.
Co-invest · 7 holders · 2014 · 2024
MOIC
–
More from Kurma Growth Opportunities
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
UKData refreshed weekly · Sourced from public filings